CD274 and colorectal carcinoma: This meta-analysis showed that the ORR of immunotherapy was 14% in the PD-L1( +) and 32% in the PD-L1(-) subgroup.PD-L1 expression in CRC cells may be a predictive biomarker of response to immunotherapy.